Osteoporosis therapy with bisphosphonates. Once weekly is enough
MMW Fortschritte der Medizin 143(44): 58
2001
ISSN/ISBN: 1438-3276 PMID: 11732404 Document Number: 534151
Document emailed within 1 workday
Related Documents
2003: Evidence-based assessment of therapeutic agents of osteoporosis. Bisphosphonates, SERM and basic therapy in front MMWFortschrittederMedizin 145(27-28): 63Maillefert, J.F.; Sibilia, J.; Bertin, P.; Tavernier, C. 1999: Bisphosphonates in rheumatoid arthritis (osteoporosis excluded) Revue du Rhumatisme 66(10): 442-445
Homik, J.E.; Cranney, A.; Shea, B.; Tugwell, P.; Wells, G.; Adachi, J.D.; Suarez-Almazor, M.E. 1999: A metaanalysis on the use of bisphosphonates in corticosteroid induced osteoporosis Journal of Rheumatology 26(5): 1148-1157
Aksaranugraha, S. 2015: BMD Changes Following 2-Year Treatment of Osteoporosis by using BMK to Monitor the Dose of Bisphosphonates Journal of the Medical Association of Thailand 98 Suppl. 8: S8-12
Chumworathayi, B.; Suprasert, P.; Charoenkwan, K.; Srisomboon, J.; Phongnarisorn, C.; Siriaree, S.; Cheewakriangkrai, C.; Tantipalakorn, J.; Kiatpeerakul, C.; Pantusart, A. 2005: Weekly versus three-weekly cisplatin as an adjunct to radiation therapy in high-risk stage I-IIA cervical cancer after surgery: a randomized comparison of treatment compliance Journal of the Medical Association of Thailand 88(11): 1483-1492
Ijiri, S. 2008: Patient's preference for the daily and weekly bisphosphonate--evaluation from questionnaire of osteoporosis patients Nihon Rinsho. Japanese Journal of Clinical Medicine 66(1): 205-211
Iwamoto, J. 2010: Effects of SERMs on bone health. Discrimination of SERMs from bisphosphonates in the treatment of postmenopausal osteoporosis Clinical Calcium 20(3): 396-407
Lüftner, D.; Henschke, P.; Possinger, K. 2007: Clinical value of bisphosphonates in cancer therapy Anticancer Research 27(4a): 1759-1768
Braun, E.; Iacono, V.J. 2006: Bisphosphonates: case report of nonsurgical periodontal therapy and osteochemonecrosis International Journal of Periodontics and Restorative Dentistry 26(4): 315-319
Diel, I.J.; Solomayer, E.F. 1996: Bisphosphonates in anti-osteolytic therapy of metastasizing breast carcinoma Zentralblatt für Gynakologie 118(10): 582-586
Heidelmann, G. 1979: Problems of high-dose sodium fluoride therapy in osteoporosis. 3. Practice of osteoporosis therapy with sodium fluoride Zeitschrift für Arztliche Fortbildung 73(12): 581-584
2006: Bisphosphonates effective in preventing bone complications associated with androgen deprivation therapy Journal of Supportive Oncology 4(2): 99-100
Scharla, S.H. 1999: Therapy of osteoporosis: native vitamin D or as hormone? Advantages of activated vitamin D in secondary osteoporosis MMW Fortschritte der Medizin 141(31-32): 32-36
Kimura, M.; Sano, M.; Tabei, T.; Asaga, T.; Ando, J.; Fujii, H.; Yamamoto, N.; Kurosumi, M. 2005: Study of three-weekly docetaxel and weekly trastuzumab treatment in HER 2-overexpressing metastatic breast cancer patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(3): 335-339
Supasyndh, O.; Satirapoj, B.; Seenamngoen, S.; Yongsiri, S.; Choovichian, P.; Vanichakarn, S. 2009: Nutritional status of twice and thrice-weekly hemodialysis patients with weekly Kt/V > 3.6 Journal of the Medical Association of Thailand 92(5): 624-631
Lui, S.F.; Law, C.B.; Ting, S.M.; Li, P.; Lai, K.N. 1991: Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis Clinical Nephrology 36(5): 246-251
Rawat, S.; Srivastava, H.; Ahlawat, P.; Pal, M.; Gupta, G.; Chauhan, D.; Tandon, S.; Khurana, R. 2016: Weekly versus Three-Weekly Cisplatin-based Concurrent Chemoradiotherapy as definitive treatment in Head and Neck Cancer- Where do we stand? Gulf Journal of Oncology 1(21): 6-11
Sinha, P.P.; Frich, J.C. 1988: Postoperative radiation therapy with weekly 5 fluorouracil West Virginia Medical Journal 84(11): 511-515
Chanpattana, W.; Chakrabhand, M.L.; Kitaroonchai, W.; Choovanichvong, S.; Prasertsuk, Y. 1999: Effects of twice- versus thrice-weekly electroconvulsive therapy in schizophrenia Journal of the Medical Association of Thailand 82(5): 477-483
Takahashi, H.; Takahashi, M.; Taguchi, K.; Sasaki, F.; Todo, S. 2003: Weekly paclitaxel administration in the adjuvant therapy of primary breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(5): 653-659